Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Acrux.
RELATED STOCKHEAD STORIES
Health & Biotech
Check Up: ASX biotech comes alive as health stocks tackle international markets
Health & Biotech
ASX Health Stocks: HeraMed jumps 11pc on survey results, while Acrux seeks FDA approval for acne gel
News
Market Highlights and 5 ASX Small Caps to watch on Monday
Health & Biotech
ASX Health Stocks: Acrux flags testosterone solution with an armpit application, Clinuvel posts record revenues
Health & Biotech
ScoPo’s Powerplays: Solid earnings for health stocks all round, but price action stays with larger caps
Health & Biotech
ASX Health Stocks: Chimeric gets licence for CAR-T from U-Pen, Acrux gets nod from the FDA
Health & Biotech
The surge and plunge in ASX biotech shows what the FDA giveth, the FDA taketh away
Health & Biotech
ScoPo’s Powerplays: Buying opportunities in a volatile week
Health & Biotech
Check Up: From Moderna’s effective jabs to Patrys’ brain cancer breakthrough
Health & Biotech
Suda Pharma pops 44pc on cap raise; Acrux and other biotechs whet investor appetites
News
Closing Bell: Today’s biggest small cap movers on the ASX
Health & Biotech
Acrux shares gain after FDA approves its toenail fungus treatment
News
10 at 10: These ASX stocks are in the upper echelon of performers this morning
Health & Biotech
ScoPo’s Powerplays: Biogen drama, M&A action, and profit-taking coloured the week in healthcare
Experts
MoneyTalks: This biotech focused fund explains why it invested $15m in these 2 ASX stocks
News
Directors’ Trades: Which ASX company director put another $3.6 million into their gold stock?
News